FDA NDC Directory · JSON-LD · Markdown

Trelegy Ellipta

NDC 0173-0893 · HUMAN PRESCRIPTION DRUG · POWDER

Generic namefluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryNew Drug Application (innovator) · App NDA209482
Dosage form / routePOWDER · RESPIRATORY (INHALATION)
Active ingredientsFLUTICASONE FUROATE (200 ug/1)
UMECLIDINIUM BROMIDE (62.5 ug/1)
VILANTEROL TRIFENATATE (25 ug/1)
Marketing started20200909
Package count3

External sources

Source: openFDA. Public-domain (CC0).